The efficacy of Sonographic and biological pleurodesis Indicators of Malignant Pleural Effusion (SIMPLE) - a randomised trial
Completed
- Conditions
- 1002765610035597malignant pleural effusion (MPE)fluid around the lung caused by cancer
- Registration Number
- NL-OMON44184
- Lead Sponsor
- Oxford Respiratory Trials Unit, University of Oxford
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
1. Clinically confident diagnosis of MPE requiring pleurodesis
2. written informed consent
Exclusion Criteria
1. Age <18 yrs
2. Poor prognosis (pleurodesis not offered in normal practice)
3. Irreversible contra-indication to drain insertion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Length of hospital stay (in days) during the initial hospitalisation. (from the<br /><br>time of randomisation until declared fit for discharge from hospital)</p><br>
- Secondary Outcome Measures
Name Time Method <p>1. Pleurodesis success at 1 and 3 months post randomisation (radiological and<br /><br>clinical evaluation to assess success at 1 and 3 months (need for further<br /><br>pleural interventions))<br /><br><br /><br>2. Number of days in hospital post randomisation with drain in situ.(from<br /><br>randomisation till drain removal)<br /><br><br /><br>3. EQ-5D-5L questionnaire (at presentation, 1 and 3 months post randomisation)<br /><br><br /><br>4. VAS assessment (at baseline and post pleurodesis (Daily for 7 days and then<br /><br>weekly for 4 weeks))<br /><br><br /><br>5. Healthcare utilisation logs (at discharge, 1 and 3 months post randomisation)<br /><br><br /><br>6. Mortality (at 12 months post randomisation)<br /><br><br /><br>7. Pleurodesis failure at 1 and 3 months post randomisation (radiological and<br /><br>clinical evaluations to assess success at 1 and 3 months (need for further<br /><br>pleural interventions))</p><br>